ZIOPHARM ONCOLOGY INC's ticker is ZIOP and the CUSIP is 98973P101. A total of 159 filers reported holding ZIOPHARM ONCOLOGY INC in Q3 2020. The put-call ratio across all filers is 1.22 and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q1 2022 | $9,000 | -10.0% | 13,969 | +47.3% | 0.00% | – |
| Q4 2021 | $10,000 | +42.9% | 9,486 | +146.6% | 0.00% | – |
| Q3 2021 | $7,000 | +75.0% | 3,846 | +160.6% | 0.00% | – |
| Q2 2021 | $4,000 | – | 1,476 | +4512.5% | 0.00% | – |
| Q1 2021 | $0 | -100.0% | 32 | -93.6% | 0.00% | – |
| Q2 2020 | $2,000 | +100.0% | 500 | 0.0% | 0.00% | – |
| Q1 2020 | $1,000 | -50.0% | 500 | 0.0% | 0.00% | – |
| Q4 2019 | $2,000 | 0.0% | 500 | 0.0% | 0.00% | – |
| Q3 2019 | $2,000 | -33.3% | 500 | 0.0% | 0.00% | – |
| Q2 2019 | $3,000 | -91.4% | 500 | -95.5% | 0.00% | – |
| Q3 2018 | $35,000 | +6.1% | 11,000 | 0.0% | 0.00% | – |
| Q2 2018 | $33,000 | -23.3% | 11,000 | 0.0% | 0.00% | – |
| Q1 2018 | $43,000 | -6.5% | 11,000 | 0.0% | 0.00% | – |
| Q4 2017 | $46,000 | -32.4% | 11,000 | 0.0% | 0.00% | – |
| Q3 2017 | $68,000 | 0.0% | 11,000 | 0.0% | 0.00% | – |
| Q2 2017 | $68,000 | -2.9% | 11,000 | 0.0% | 0.00% | – |
| Q1 2017 | $70,000 | +18.6% | 11,000 | 0.0% | 0.00% | – |
| Q4 2016 | $59,000 | -4.8% | 11,000 | 0.0% | 0.00% | – |
| Q3 2016 | $62,000 | +3.3% | 11,000 | 0.0% | 0.00% | – |
| Q2 2016 | $60,000 | -26.8% | 11,000 | 0.0% | 0.00% | – |
| Q1 2016 | $82,000 | -9.9% | 11,000 | 0.0% | 0.00% | – |
| Q4 2015 | $91,000 | -8.1% | 11,000 | 0.0% | 0.00% | – |
| Q3 2015 | $99,000 | -25.0% | 11,000 | 0.0% | 0.00% | -100.0% |
| Q2 2015 | $132,000 | +11.9% | 11,000 | 0.0% | 0.00% | – |
| Q1 2015 | $118,000 | +110.7% | 11,000 | 0.0% | 0.00% | – |
| Q4 2014 | $56,000 | +93.1% | 11,000 | 0.0% | 0.00% | – |
| Q3 2014 | $29,000 | -34.1% | 11,000 | 0.0% | 0.00% | – |
| Q2 2014 | $44,000 | -12.0% | 11,000 | 0.0% | 0.00% | – |
| Q1 2014 | $50,000 | +4.2% | 11,000 | 0.0% | 0.00% | – |
| Q4 2013 | $48,000 | +11.6% | 11,000 | 0.0% | 0.00% | – |
| Q3 2013 | $43,000 | +87.0% | 11,000 | 0.0% | 0.00% | – |
| Q2 2013 | $23,000 | – | 11,000 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| DISCOVERY CAPITAL MANAGEMENT, LLC / CT | 14,013,093 | $9,142,000 | 0.78% |
| MSD Partners, L.P. | 15,151,516 | $9,885,000 | 0.54% |
| MSD Partners, L.P. | 7,575,758 | $4,942,000 | 0.27% |
| CHIRON CAPITAL MANAGEMENT, LLC | 144,960 | $95,000 | 0.06% |
| MAGNOLIA CAPITAL ADVISORS LLC | 185,456 | $121,000 | 0.05% |
| Allred Capital Management, LLC | 128,000 | $83,000 | 0.04% |
| Virtus ETF Advisers LLC | 131,413 | $86,000 | 0.04% |
| GSA CAPITAL PARTNERS LLP | 232,438 | $152,000 | 0.02% |
| ACT WEALTH MANAGEMENT, LLC | 37,071 | $24,000 | 0.01% |
| Pathway Financial Advisors LLC | 30,000 | $20,000 | 0.01% |